CAS: 179324-69-7 - Bortezomib
Formula:C19H25BN4O4
InChI:InChI=1S/C19H25BN4O4/c1-13(2)10-17(20(27)28)24-18(25)15(11-14-6-4-3-5-7-14)23-19(26)16-12-21-8-9-22-16/h3-9,12-13,15,17,27-28H,10-11H2,1-2H3,(H,23,26)(H,24,25)/t15-,17-/m0/s1
InChI key:InChIKey=GXJABQQUPOEUTA-RDJZCZTQSA-N
SMILES:O=C(NC(C(=O)NC(B(O)O)CC(C)C)CC=1C=CC=CC1)C2=NC=CN=C2
- Synonyms:
- B-[(1R)-3-Methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic acid
- Boronic acid, B-[(1R)-3-methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]-
- Boronic acid, [(1R)-3-methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]-
- Boronic acid, [3-methyl-1-[[1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]-, [S-(R*,S*)]-
- Bortezomib for research
- Bortizomib
- Brotezamide
- Dpba
- Ldp 341
- Mg 341
- See more synonyms
- Mln 341
- N-[(1R)-1-(dihydroxyboranyl)-3-methylbutyl]-Nalpha-(pyrazin-2-ylcarbonyl)-L-phenylalaninamide
- N-[(1S)-1-(dihydroxyboranyl)-3-methylbutyl]-Nalpha-(pyrazin-2-ylcarbonyl)-D-phenylalaninamide
- NSC 681239
- PS 341 (pharmaceutical)
- Ps 314
- Ps 341
- Radiciol
- Velcade
- [(1R)-3-Methyl-1-[[(2S)-1-Oxo-3-Phenyl-2-[(Pyrazinylcarbonyl)Amino]Propyl]Amino]Butyl]-Boronic Acid
Bortezomib
CAS:179324-69-7
Formula:
C19H25BN4O4
Purity:
>98.0%(HPLC)
Color and Shape:
White to Almost white powder to crystal
Molecular weight:
384.24
Ref: 3B-B5741
10mg | 75.00 € | ||
50mg | 217.00 € |
Estimated delivery in United States, on Monday 30 Dec 2024
Bortezomib, 98%
CAS:179324-69-7
A potent, highly selective and reversible inhibitor of the 20S proteasome, Bortezomib is used as …
Formula:
C19H25BN4O4
Purity:
98%
Color and Shape:
White to off-white, Powder or crystals or crystalline powder
Molecular weight:
384.24
Ref: 02-J60378
10mg | 272.00 € | ||
25mg | 513.00 € |
Estimated delivery in United States, on Thursday 2 Jan 2025
Boronic acid, B-[(1R)-3-methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]-
CAS:179324-69-7
Formula:
C19H25BN4O4
Purity:
98%
Color and Shape:
Solid
Molecular weight:
384.2372
Ref: IN-DA0026XG
1g | 177.00 € | ||
5g | 499.00 € | ||
5mg | 41.00 € | ||
25mg | 51.00 € | ||
50mg | 56.00 € | ||
100mg | 66.00 € | ||
250mg | 109.00 € | ||
500mg | 154.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Bortezomib
CAS:179324-69-7
Formula:
C19H25BN4O4
Purity:
98% (nmr) (Typical Value in Batch COA)
Color and Shape:
white solid
Molecular weight:
384.24g/mol
Ref: 54-BISN0125
5mg | 139.00 € | ||
10mg | 175.00 € | ||
50mg | 216.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Bortezomib
CAS:179324-69-7
Formula:
C19H25BN4O4
Purity:
≥ 98.0%
Color and Shape:
White to off-white powder or solid
Molecular weight:
384.24
Ref: 7W-GP0262
5mg | 116.00 € | ||
25mg | 347.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Bortezomib Trimer ((1R,2S)-Bortezomib Trimer)
Formula:
C57H69B3N12O9
Color and Shape:
White To Off-White Solid
Molecular weight:
1098.68
Ref: 4Z-B-461
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Bortezomib
CAS:179324-69-7
Bortezomib (LDP 341) is a 20S proteasome inhibitor (Ki=0.6 nM) that is reversible and selective.
Formula:
C19H25BN4O4
Purity:
100% - 99.97%
Color and Shape:
Yellow Solid
Molecular weight:
384.24
Ref: TM-T2399
5mg | 50.00 € | ||
10mg | 61.00 € | ||
25mg | 76.00 € | ||
50mg | 92.00 € | ||
100mg | 138.00 € | ||
200mg | 214.00 € | ||
500mg | 354.00 € | ||
1mL*10mM (DMSO) | 50.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
Ref: 4Z-B-4697
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Monday 13 Jan 2025
Bortezomib
Controlled ProductCAS:179324-69-7
Stability Hygroscopic and Moisture Sensitive Applications Bortezomib is the first proteasome inhibitor to be approved …
Formula:
C19H25BN4O4
Color and Shape:
White To Off-White
Molecular weight:
384.24
Ref: TR-B675700
5mg | 106.00 € | ||
10mg | 209.00 € | ||
100mg | 996.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Bortezomib-D8 (Major)
Controlled ProductCAS:179324-69-7
Applications Labelled Bortezomib, which the first proteasome inhibitor to be approved by the US FDA …
Formula:
C19H17D8BN4O4
Color and Shape:
Off-White
Molecular weight:
392.29
Ref: TR-B675702
1mg | 473.00 € | ||
10mg | 3,200.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Bortezomib - Bio-X ™
CAS:179324-69-7
Bortezomib is a selective and reversible inhibitor of the multicatalytic 26S proteasome. The inhibition of …
Formula:
C19H25BN4O4
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
384.24 g/mol
Ref: 3D-BB164258
10mg | 164.00 € |
Estimated delivery in United States, on Wednesday 15 Jan 2025
Bortezomib
CAS:179324-69-7
Selective and reversible inhibitor of the multicatalytic 26S proteasome. The inhibition of protein breakdown affects …
Formula:
C19H25BN4O4
Purity:
Min. 95%
Color and Shape:
White Powder
Molecular weight:
384.24 g/mol
Ref: 3D-FM19000
1g | 633.00 € | ||
50mg | 160.00 € | ||
100mg | 217.00 € | ||
250mg | 406.00 € | ||
500mg | 497.00 € |
Estimated delivery in United States, on Wednesday 15 Jan 2025